Obesity and type 2 diabetes risk in midadult life: The role of childhood adversity

2008 ◽  
PEDIATRICS ◽  
2008 ◽  
Vol 121 (5) ◽  
pp. e1240-e1249 ◽  
Author(s):  
C. Thomas ◽  
E. Hypponen ◽  
C. Power

Nutrients ◽  
2019 ◽  
Vol 11 (4) ◽  
pp. 841 ◽  
Author(s):  
Britt Burton-Freeman ◽  
Michał Brzeziński ◽  
Eunyoung Park ◽  
Amandeep Sandhu ◽  
Di Xiao ◽  
...  

Type 2 diabetes mellitus (T2DM) is the most common form of DM and its prevalence is increasing worldwide. Because it is a progressive disease, prevention, early detection and disease course modification are possible. Diet plays a critical role in reducing T2DM risk. Therapeutic dietary approaches routinely recommend diets high in plant foods (i.e., vegetables, fruits, whole-grains). In addition to essential micronutrients and fiber, plant-based diets contain a wide-variety of polyphenols, specifically flavonoid compounds. Evidence suggests that flavonoids may confer specific benefits for T2DM risk reduction through pathways influencing glucose absorption and insulin sensitivity and/or secretion. The present review assesses the relationship between dietary flavonoids and diabetes risk reduction reviewing current epidemiology and clinical research. Collectively, the research indicates that certain flavonoids, explicitly anthocyanins and flavan-3-ols and foods rich in these compounds, may have an important role in dietary algorithms aimed to address diabetes risk factors and the development of T2DM.


2017 ◽  
Vol 2017 ◽  
pp. 1-16 ◽  
Author(s):  
James C. Barton ◽  
Ronald T. Acton

Diabetes in whites of European descent with hemochromatosis was first attributed to pancreatic siderosis. Later observations revealed that the pathogenesis of diabetes inHFEhemochromatosis is multifactorial and its clinical manifestations are heterogeneous. Increased type 2 diabetes risk inHFEhemochromatosis is associated with one or more factors, including abnormal iron homeostasis and iron overload, decreased insulin secretion, cirrhosis, diabetes in first-degree relatives, increased body mass index, insulin resistance, and metabolic syndrome. In p.C282Y homozygotes, serum ferritin, usually elevated at hemochromatosis diagnosis, largely reflects body iron stores but not diabetes risk. In persons with diabetes type 2 without hemochromatosis diagnoses, serum ferritin levels are higher than those of persons without diabetes, but most values are within the reference range. Phlebotomy therapy to achieve iron depletion does not improve diabetes control in all persons withHFEhemochromatosis. The prevalence of type 2 diabetes diagnosed today in whites of European descent with and withoutHFEhemochromatosis is similar. Routine iron phenotyping orHFEgenotyping of patients with type 2 diabetes is not recommended. Herein, we review diabetes inHFEhemochromatosis and the role of iron in diabetes pathogenesis in whites of European descent with and withoutHFEhemochromatosis.


Diabetologia ◽  
2019 ◽  
Vol 62 (12) ◽  
pp. 2222-2232 ◽  
Author(s):  
Nasser Laouali ◽  
Francesca Romana Mancini ◽  
Mariem Hajji-Louati ◽  
Douae El Fatouhi ◽  
Beverley Balkau ◽  
...  

2012 ◽  
Vol 29 (12) ◽  
pp. e461-e467 ◽  
Author(s):  
S. C. M. van Esch ◽  
M. D. Nijkamp ◽  
M. C. Cornel ◽  
F. J. Snoek

Diabetes ◽  
2009 ◽  
Vol 59 (3) ◽  
pp. 741-746 ◽  
Author(s):  
K. A. Fawcett ◽  
E. Wheeler ◽  
A. P. Morris ◽  
S. L. Ricketts ◽  
G. Hallmans ◽  
...  

2008 ◽  
Vol 38 (1) ◽  
pp. 14-15
Author(s):  
MARY ANN MOON

Sign in / Sign up

Export Citation Format

Share Document